CN1308020C - Traditional Chinese medicine composition for treating psoriasis - Google Patents
Traditional Chinese medicine composition for treating psoriasis Download PDFInfo
- Publication number
- CN1308020C CN1308020C CNB200410011342XA CN200410011342A CN1308020C CN 1308020 C CN1308020 C CN 1308020C CN B200410011342X A CNB200410011342X A CN B200410011342XA CN 200410011342 A CN200410011342 A CN 200410011342A CN 1308020 C CN1308020 C CN 1308020C
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- chinese medicine
- traditional chinese
- psoriasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 201000004681 Psoriasis Diseases 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 208000002474 Tinea Diseases 0.000 claims abstract description 20
- 241000130764 Tinea Species 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 6
- 235000008434 ginseng Nutrition 0.000 claims abstract description 6
- 210000004072 lung Anatomy 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 6
- 241000131808 Scolopendra Species 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 208000017520 skin disease Diseases 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241001412627 Adenophora liliifolia Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 abstract 1
- 241000208843 Arctium Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 229940097275 indigo Drugs 0.000 abstract 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating psoriasis, which is prepared from ginseng, astragalus root, pilose asiabell root, Chinese yam, poria cocos, prepared rhizome of rehmannia, matrimony vine, pulp of dogwood fruit, dipsacus root, root of red rooted saliva, peach kernels, motherwort, boneol, centipede, flavescent sophora root, natural indigo, corktree bark, goldthread root, root of straight ladybell, chrysanthemum flower and arctium fruit according to the principle of treating psoriasis in traditional Chinese medicine. The clinical statistics show that the cure rate is 89%, and the total effective rate is 93%. The traditional Chinese medicine preparation has sufficient raw material sources of the required traditional Chinese medicines, is prepared according to the conventional traditional Chinese medicine processing technology, and has no pollution. Has great popularization and application value for treating tinea such as psoriasis and the like.
Description
One, technical field
The present invention is a kind of Chinese medicine preparation for the treatment of tinea, the Chinese medicine composition of tinea such as specifically a kind of treatment psoriasis (psoriasis) and tinea capitis, tinea corporis, joint tinea, the tinea manuum, tinea pedis, tinea circinata, neurodermatitis.
Two, background technology
Psoriasis is called one of three big pertinacious diseases by World Health Organization (WHO), gets patient's skin urtication, tinea piece and incrustation occur, with the bits that take off bran end sample, very easily recurrence or obstinate.Other described tinea also has similar condition of illness, and the patient suffering can't bear.
Chinese medicine and pharmacy does not have the clear and definite record pathology cause of disease and the theoretical foundation of prescription compatibility to the treatment of tinea such as psoriasis.Research and clinical practice that I go through surplus in the of 30 year, the internal organs meridians of utilization Chinese medicine look into because of, be guiding according to yin-yang and five elements, carry out the disease of distinguishing of science, the pathology cause of disease that proposes tinea such as psoriasis is that tinea is the skin disease, under the lung meridian, when controlling from the lung meridian opinion.And the psoriasic a kind of Chinese medicine composition of treatment is proposed, its component and weight are as follows: Radix Rehmanniae Preparata 25g, Fructus Lycii 20g, Radix Scrophulariae 25g, Radix Ophiopogonis 15g, Radix Glycyrrhizae 15g, Radix Paeoniae Rubra 15g, Herba Menthae 10g, Cortex Moutan 10g, Lignum Sappan 20g, Radix Salviae Miltiorrhizae 20g.(Liu Wenqi, " when controlling psoriasis from the lung meridian opinion ", " U.S. China clinical pharmacy " magazine, the publication on January 1st, 2000 of 2000 the 1st volume the 1st phase 55-56 pages or leaves) tinea mainly is positive QI-insufficiency, and deficiency of both QI and YIN is for suffering from.The deficiency of vital energy then gasification function weakens thrombosis, blood and lymph two microcirculation deficiencies in the subcutaneous tissue, gas is thanked slowly, can not rise to the greatest extent clearly, turbid can not falling to the greatest extent, yang deficiency in outside, in can not keeping, the failure of superficial QI to protect the body against disease space between skin and muscles is not hard, pathogen is easily invaded; The deficiency of YIN is in interior marrow deficiency, the deficiency of YIN can not make in outside the skin that makes moist, the gas-solid of collaborative table is defended eliminating evil.Lung is the kidney mother, and the deficiency of the lung must be taken mother-qi by force by son, causes that lung yin is not enough more, and the deficiency of YIN is outside Nei Yangbi floats on, and skin loses its rough splitting that make moist, and the marrow deficiency causes the relative lymph hyposecretion of endocrine disturbance, and antibody descends.The mutual root of this deficiency of both YIN and YANG is too late, forms the interior-deficiency exogenous dryness, feels the haze miasma again and becomes the tinea disease.
Three, summary of the invention
The present invention is based on Chinese medicine and pharmacy " tinea is the skin disease, under the lung meridian, when controlling from the lung meridian opinion " and treats.To have tonic vigour and lung insufficiency of kidney-YANG, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, open plug collateral dredging microcirculation improvement, the raw material of Chinese medicine of promoting tissue regeneration by removing blood stasis organically combines, synergism, most its effectiveness, and oral administration, but external application is again gone back oral administration and is added external application simultaneously, increase effect, purpose provides the treatment psoriasis that a kind of determined curative effect can not only cure and not recur reliably and the Chinese medicine composition of other ringworm.
Chinese medicine composition of the present invention claims that again " spirit of Wen Qike tinea " is the skin disease according to tinea, under the lung meridian, carries out composition of prescription when controlling from the lung meridian opinion.The percentage by weight of each crude drug of the present invention is as follows:
Radix Ginseng 3-6%, Radix Astragali 5-8%, Radix Codonopsis 3-6%, Rhizoma Dioscoreae 5-8%, Poria 5-8%, Radix Rehmanniae Preparata 8-13%, Fructus Lycii 5-8%, Fructus Corni 3-6%, Radix Dipsaci 6-12%, Radix Salviae Miltiorrhizae 3-6%, Semen Persicae 3-6%, Herba Leonuri 6-9%, Borneolum Syntheticum 0.15-0.4%, Scolopendra 0.3-0.6%, Radix Sophorae Flavescentis 2-5%, Indigo Naturalis 1-2%, Cortex Phellodendri 2-4%, Rhizoma Coptidis 1-4%, Radix Glehniae 5-9%, Flos Chrysanthemi 3-6%, Niu Bangzi 2-5%.
In the prescription of the present invention, Radix Ginseng, the Radix Astragali, the strong cardio-pulmonary function of Radix Codonopsis QI invigorating help the convergence of vessels in the lung and strengthen the gasification that pneumatic arteries and veins is answered, and promote that the gas promoting the circulation of blood is smooth, and the venation mediation is in order to the turbid descending the lucid yang sending up.
The Radix Astragali is the QI invigorating key medicine simultaneously in the prescription, and modern study shows that it has and extends the microvascular effect of deriving, and promotes microcirculation and lymph circulation, to promote metabolism, strengthens antibody.
Radix Rehmanniae Preparata, Rhizoma Dioscoreae, Fructus Corni, Fructus Lycii, Radix Glehniae have the deficiency of YIN of tonifying the lung kidney, the nourishing kidney lung moistening, and spermatogenesis Tianjin, the vessel softening that makes moist, cloudy gas is full can be made in outer skin moistening granulation promoting, the hard natural fibre line of meat Gu Wei of collaborative table gas, and the secretion that can be lymph provides material base, and strengthens antibody.
Radix Dipsaci, Radix Salviae Miltiorrhizae, the Radix Astragali can promote tissue regeneration to repair focus.
Semen Persicae, Radix Salviae Miltiorrhizae, Scolopendra, Rhizoma Coptidis blood circulation promoting and blood stasis dispelling are opened the plug collateral dredging, and microcirculation improvement strengthens metabolism.
Poria can help the lucid yang sending up by spleen invigorating diuresis the turbid descending.
Radix Adenophorae (Radix Glehniae), Rhizoma Dioscoreae, Radix Codonopsis, Fructus Lycii nourishing YIN and clearing away lung-heat, moistening lung and nourishing throat, supplementing QI for promoting the production of body fluid, strengthening governor of water for restraining hyperactivity of yang.
But Indigo Naturalis, Radix Sophorae Flavescentis, Cortex Phellodendri, Rhizoma Coptidis, Scolopendra heat-clearing and toxic substances removing are with gram skin infection furuncle carbuncle, skin pruritus, scabies, herpes.
The skin pruritus of can curing Flos Chrysanthemi, Niu Bangzi, Radix Sophorae Flavescentis, Borneolum Syntheticum etc. suppresses fungus and dispels stubborn dermatitis.
When controlling prescription from the lung meridian opinion, tonic vigour is controlled the method that tinea is a treating both the principal and secondary aspects of a disease, makes each organ dysfunction of health return to original health status again, no longer recurrence after not only stubborn dermatitis can heal and heal.
The present invention can be made into capsule, and oral administration, but also external application are gone back oral administration and added external application simultaneously.Capsule need only be put into eliminating cold for resuscitation water during external application, can the furnishing pasty state be coated on the tinea face and get final product.
The present invention goes through the clinical practice in year surplus in the of 30 and tests effect repeatly repeatly.Reach 89% according to the clinical statistics cure rate, total effective rate reaches 93%.According to 2000 to once adding external application for curing psoriatic 15 people simultaneously and verified with the Chinese medicine composition of the present invention prescription is for oral administration, healings in wherein average 8 years do not recurred, and do not recur after elder was healed in 15 years.This is to show that the present invention has definite curative effect reliably.
Each crude drug in the present invention's prescription does not contain national resources protection veriety, crude drug source abundance, and mature preparation process, pollution-free has application value.
The present invention can produce according to national Chinese medicinal capsule agent manufacturing process standard and make capsule.
Four, the specific embodiment:
The percentage by weight of the crude drug of most preferred embodiment of the present invention is:
Radix Ginseng 4%, the Radix Astragali 7.5%, Radix Codonopsis 4.5%, Rhizoma Dioscoreae 7.5%, Poria 7.5%, Radix Rehmanniae Preparata 12%, Fructus Lycii 7.5%, Fructus Corni 3.5%, Radix Dipsaci 7.5%, Radix Salviae Miltiorrhizae 4%, Semen Persicae 4.5%, Herba Leonuri 7.5%, Borneolum Syntheticum 0.25%, Scolopendra 0.4%, Radix Sophorae Flavescentis 2.3%, Indigo Naturalis 1.15%, Cortex Phellodendri 2.4%, Rhizoma Coptidis 1.5%, Radix Glehniae 8%, Flos Chrysanthemi 4%, Niu Bangzi 2.5%.
Claims (2)
1, a kind of Chinese medicine composition for the treatment of psoriasis is the skin disease by tinea, when controlling composition of prescription from the lung meridian opinion, it is characterized in that the percentage by weight of each crude drug is as follows:
Radix Ginseng 3-6%, Radix Astragali 5-8%, Radix Codonopsis 3-6%, Rhizoma Dioscoreae 5-8%, Poria 5-8%, Radix Rehmanniae Preparata 8-13%, Fructus Lycii 5-8%, Fructus Corni 3-6%, Radix Dipsaci 6-12%, Radix Salviae Miltiorrhizae 3-6%, Semen Persicae 3-6%, Herba Leonuri 6-9%, Borneolum Syntheticum 0.15-0.4%, Scolopendra 0.3-0.6%, Radix Sophorae Flavescentis 2-5%, Indigo Naturalis 1-2%, Cortex Phellodendri 2-4%, Rhizoma Coptidis 1-4%, Radix Glehniae 5-9%, Flos Chrysanthemi 3-6%, Niu Bangzi 2-5%.
2, a kind of as the said a kind of Chinese medicine composition for the treatment of psoriasis of claim 1, it is characterized in that the percentage by weight of each crude drug is as follows:
Radix Ginseng 4%, the Radix Astragali 7.5%, Radix Codonopsis 4.5%, Rhizoma Dioscoreae 7.5%, Poria 7.5%, Radix Rehmanniae Preparata 12%, Fructus Lycii 7.5%, Fructus Corni 3.5%, Radix Dipsaci 7.5%, Radix Salviae Miltiorrhizae 4%, Semen Persicae 4.5%, Herba Leonuri 7.5%, Borneolum Syntheticum 0.25%, Scolopendra 0.4%, Radix Sophorae Flavescentis 2.3%, Indigo Naturalis 1.15%, Cortex Phellodendri 2.4%, Rhizoma Coptidis 1.5%, Radix Glehniae 8%, Flos Chrysanthemi 4%, Niu Bangzi 2.5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410011342XA CN1308020C (en) | 2004-12-13 | 2004-12-13 | Traditional Chinese medicine composition for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410011342XA CN1308020C (en) | 2004-12-13 | 2004-12-13 | Traditional Chinese medicine composition for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1736455A CN1736455A (en) | 2006-02-22 |
| CN1308020C true CN1308020C (en) | 2007-04-04 |
Family
ID=36079529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200410011342XA Expired - Fee Related CN1308020C (en) | 2004-12-13 | 2004-12-13 | Traditional Chinese medicine composition for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1308020C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102397435A (en) * | 2011-11-03 | 2012-04-04 | 铜陵市松马食品包装机械制造有限责任公司 | Tea cream for treating psoriasis and preparation method thereof |
| CN104707029B (en) * | 2015-03-31 | 2018-05-22 | 山东省立医院 | A kind of Chinese medicine for treating psoriasis |
| CN105106457A (en) * | 2015-09-08 | 2015-12-02 | 粘芙蓉 | Traditional Chinese medicine for treating erythrasma |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214261A (en) * | 1998-10-21 | 1999-04-21 | 余际康 | Oral medicine for curing dermatosis |
| CN1304731A (en) * | 2000-01-06 | 2001-07-25 | 王乃正 | Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| CN1358539A (en) * | 2001-12-14 | 2002-07-17 | 徐铁民 | Ulcer treating and skin increasing ointment and preparation method thereof |
| CN1362068A (en) * | 2000-12-30 | 2002-08-07 | 李毅 | Rheumatoid disease treating capsule |
| CN1425451A (en) * | 2003-01-15 | 2003-06-25 | 张淑霞 | Baikangtie plaster and its preparing method |
-
2004
- 2004-12-13 CN CNB200410011342XA patent/CN1308020C/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214261A (en) * | 1998-10-21 | 1999-04-21 | 余际康 | Oral medicine for curing dermatosis |
| CN1304731A (en) * | 2000-01-06 | 2001-07-25 | 王乃正 | Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| CN1362068A (en) * | 2000-12-30 | 2002-08-07 | 李毅 | Rheumatoid disease treating capsule |
| CN1358539A (en) * | 2001-12-14 | 2002-07-17 | 徐铁民 | Ulcer treating and skin increasing ointment and preparation method thereof |
| CN1425451A (en) * | 2003-01-15 | 2003-06-25 | 张淑霞 | Baikangtie plaster and its preparing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1736455A (en) | 2006-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1062144C (en) | Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1356138A (en) | Medicine for treating cardiovascular and cerebrovascular diseases of old people | |
| CN101028481A (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1308020C (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN1077789C (en) | Bathing preparation and making method thereof | |
| CN101129967A (en) | Traditional Chinese medicine for treating diabetic diarrhea | |
| CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
| CN1208075C (en) | Healthy fermentative wine preparation | |
| CN104013806B (en) | A kind of Chinese prescription for being used to treat diabetes | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN1357362A (en) | Jinyinxiaoshi powder | |
| CN1772092A (en) | Chinese medicine for treating kidney deficiency caused sterility | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN1319587C (en) | Medicine powder for liver and spleen diseases | |
| CN1055220C (en) | Chinese drug for treatment of hemiplegia | |
| CN1207021C (en) | Chinese patent medicine for curing gastropathy | |
| CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
| CN1054051C (en) | Medicine for treating phthisis and its preparation | |
| CN1038307C (en) | Renal failure resistant medicine | |
| CN1203799A (en) | Compound quick-acting hypotensive medicine and its preparation method | |
| CN112294928A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
| CN111329927B (en) | Traditional Chinese medicine for treating female idiopathic edema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |